Emerging Technologies Live
image by ipopba from Getty Images Pro

Virotherapy

Background

Virotherapy is a type of cancer treatment that uses viruses to kill cancer cells. Viruses are injected into the body, where they target and kill cancer cells. This treatment is still in the early stages of development, and more research is needed to determine its effectiveness.

Some of the emerging trends in virotherapy include the use of oncolytic viruses for cancer treatment, the use of viruses for the delivery of gene therapy vectors, and the use of viruses for the treatment of infectious diseases.

See live data on companies, R&D, markets, and news

In order to access the link, you need a Mergeflow account.

No Mergeflow account yet?

No credit card, no software to install. Trial ends automatically after 14 days.

Teams and individuals from across industries and tech sectors use Mergeflow

Curious to see how it works?

Watch our free video course:

Frequently asked questions about the trial

After you sign up, you’ll receive an email from us with an account activation link. Over the course of the trial, we’ll send you emails with tips and tricks. The trial ends automatically after 14 days. No further obligations on your part.

No. We do not ask for your credit card up front, so you will only be charged when you decide to buy a subscription.

No. Mergeflow is a SaaS software that runs in any modern web browser. And because it’s a subscription, you get constant product updates.

You can pay your Innovator or Analyst subscription via credit card (American Express, MasterCard, Visa) or SEPA Direct Debits. The larger team plans, API and enterprise solutions can be paid via invoicing and bank transfer.

 

Yes. We don’t serve ads, we never sell anything you give us, and we protect your privacy.